CPT® Code 91314

Deleted

1. Indications

The CPT® Code 91314 is indicated for the vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), specifically for individuals who are at risk of contracting coronavirus disease (COVID-19). The vaccine is particularly recommended for:

• Individuals aged 6 through 11 years who have already been vaccinated against COVID-19, as a booster to enhance their immune response.

2. Procedure

The administration of the COVID-19 vaccine coded under CPT® 91314 involves several key procedural steps that ensure the vaccine is delivered effectively and safely. The following steps outline the procedure:

• Step 1: Preparation of the Vaccine The vaccine must be prepared according to the manufacturer's guidelines. This includes ensuring that the vaccine is at the appropriate temperature and that it is mixed properly if required. The healthcare provider should verify the expiration date and inspect the vial for any particulate matter or discoloration before use.
• Step 2: Patient Assessment Prior to administration, the healthcare provider should conduct a thorough assessment of the patient’s medical history, including any previous allergic reactions to vaccines, current medications, and overall health status. This assessment helps to identify any contraindications to the vaccine.
• Step 3: Administration of the Vaccine The vaccine is administered via intramuscular injection, typically in the deltoid muscle of the upper arm. The provider should use a sterile syringe and needle, and the injection site should be cleaned with an alcohol swab to minimize the risk of infection. The vaccine is injected slowly and steadily to ensure proper delivery.
• Step 4: Post-Administration Monitoring After the vaccine is administered, the patient should be monitored for a short period, usually 15 to 30 minutes, to observe for any immediate adverse reactions. This monitoring is crucial, especially for individuals with a history of allergies.

3. Post-Procedure

Following the administration of the COVID-19 vaccine, patients may experience mild side effects, which are common and typically resolve within a few days. These may include soreness at the injection site, fatigue, headache, muscle pain, chills, fever, or nausea. Patients should be advised to rest and hydrate adequately. It is also important to inform them about the signs of any severe allergic reactions, such as difficulty breathing or swelling of the face and throat, and to seek immediate medical attention if these occur. Additionally, patients should be encouraged to keep their vaccination records updated and to follow any recommended guidelines for subsequent doses or boosters as advised by healthcare professionals.